The Cancer Letter
The leading independent source for information on the issues that shape oncology since 1973. cancerletter.com
- After a brief government shutdown, FY26 funding bill is signed into law NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored cancerletter.com/capitol-hill/202602…
- #BlackHistoryMonth: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention “Trying to realize how good we actually could be if our system were truly efficient is what Otis is all about” cancerletter.com/black-history-month…
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center cancerletter.com/conversation-with-t…
- UTSW researchers boost the power of CAR T cells to fight cancer cancerletter.com/clinical-roundup/20…
- “Cancer centers need a reliable partnership with the government,” said Ramon Parsons, director of Tisch Cancer Institute. cancerletter.com/podcastc/20260130_1/
- “I will not vote to fund the illegal DHS and ICE operations that terrorize the city of Chicago, Minneapolis, and so many other communities,” Sen. Dick Durbin (D-IL) said in a statement. cancerletter.com/capitol-hill/202601…
- Jennifer Dahne named director of Research Innovation and Integration at MUSC cancerletter.com/in-brief/20260130_7d/
- Les Biller, founding director of the Sheri and Les Biller Family Foundation: "So many of us know the emotional, mental, and physical toll cancer can have not just on the person with the diagnosis, but on loved ones, too." cancerletter.com/trials-and-tribulat…
- Oral bacterium may promote breast cancer development and spread, Hopkins study finds cancerletter.com/clinical-roundup/20…
- Tens of thousands of healthcare workers strike across the country cancerletter.com/cancer-policy/20260…
- In this week's issue of TCL, Gary Schwartz and Ramon Parsons focused on recent changes in the way the Cancer Center Support Grants are reviewed. cancerletter.com/podcastc/20260130_1/
- HanchorBio and WuXi Biologics form partnership to advance next-generation bi- and multi-functional fusion protein pipeline cancerletter.com/drugs-and-targets/2…
- Abdallah’s first diagnosis of a sarcoma was an event no one plans on. Abdallah knew his cancer was not curable when it returned two years later. Upon recurrence, when Shauna was three months pregnant, doctors estimated he had one to two years to live. cancerletter.com/obituary/20260130_3/
- Gustavo Rivero to lead translational research for hematologic malignancies at Tampa General Hospital Cancer Institute cancerletter.com/in-brief/20260130_7c/
- Lab-grown organoids reveal how glioblastoma resists treatment cancerletter.com/clinical-roundup/20…
- "Supportive care should be an essential part of cancer care in America, not a luxury or an afterthought," writes Les Biller, founding director of the Sheri and Les Biller Family Foundation. cancerletter.com/trials-and-tribulat…
- “Our hope is that this will one day offer patients a new option—one that not only treats the cancer but also re-engineers the immune system’s ability to fight it,” said Nancy Klauber-DeMore, MD. cancerletter.com/sponsored-article/2…
- Labcorp and Roche collaborate to expand access to advanced precision testing cancerletter.com/drugs-and-targets/2…
- FDA delays drug reviews in new voucher program amid safety, efficacy concerns cancerletter.com/cancer-policy/20260…
- An argument can be made that anyone who has attempted to follow the path of spending bills on Capitol Hill over the past few weeks should be evaluated for whiplash. cancerletter.com/capitol-hill/202601…
- “The sun dared to rise today in a sunrise he certainly would have basked in with his beautiful smile on display. At 42 years and 23 days old, the greatest human I’ve ever met took his last breath,” Shauna Erickson-Abou Zahr, about her husband's death. cancerletter.com/obituary/20260130_3/
- Trodelvy added to NCCN guidelines as preferred regimen option for first-line metastatic TNBC cancerletter.com/drugs-and-targets/2…
- Itismeran autogene + Keytruda demonstrated improvement in recurrence-free survival in neoadjuvant melanoma cancerletter.com/clinical-roundup/20…
- As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding” to enable investigators to keep their labs open until better times return. (@caseccc.bsky.social) cancerletter.com/podcastc/20260130_1/
- Dario Altieri to step down as president of The Wistar Institute cancerletter.com/in-brief/20260130_7b/
- CMS to enter negotiations with drugmakers over the price of four cancer medications cancerletter.com/cancer-policy/20260…
- FDA approves Darzalex Faspro as quad regimen for all newly diagnosed MM cancerletter.com/drugs-and-targets/2…
- Antibody halts triple-negative breast cancer in preclinical models. By Hayley Kamin, PhD. cancerletter.com/sponsored-article/2…
- Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore - guest editorial by Les Biller cancerletter.com/trials-and-tribulat…
- Anirban Maitra named director of NYU Perlmutter Cancer Center cancerletter.com/in-brief/20260130_7a/
- NIH suspends new embryonic stem cell line submissions cancerletter.com/cancer-policy/20260…
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42 cancerletter.com/obituary/20260130_3/
- FY26 funding package blocked in Senate after ICE shooting of Alex Pretti New package—likely excluding DHS—may go back to House early next week cancerletter.com/capitol-hill/202601…
- The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding) Cancer centers fund small grants to boost morale amid low paylines cancerletter.com/podcastc/20260130_1/
- Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology. cancerletter.com/in-the-archives/202…
- Researchers find cell markers to track TNBC, Baylor College of Medicine study finds (@bcmhouston.bsky.social) cancerletter.com/clinical-roundup/20…
- Premarin’s 84 years of dominance came from blocking competitors from entering the racetrack. With this approval, has Premarin’s monopoly been put out to pasture?https://cancerletter.com/clinical/20260123_1/
- The House bill provides $47.2 billion for NIH’s base budget, an increase of $415 million (+0.9%) over FY25. This includes a $128 million increase for NCI and $100 million increase for Alzheimer’s research. cancerletter.com/capitol-hill/202601…
- Kathie-Ann Joseph to lead breast surgery program at Rutgers & RWJBarnabas Health (@rutgerscancer.bsky.social, @rwjms.bsky.social) cancerletter.com/in-brief/20260123_8d/
- "This rapidly and dramatically changing landscape for healthcare and science demands that we re-examine everything we do for patients, caregivers, families, researchers, and the entire blood cancer community," writes E. Anders Kolb, MD. cancerletter.com/guest-editorial/202…
- Extracellular vesicles drug delivery mechanism could aid breast cancer treatment, UF study finds cancerletter.com/clinical-roundup/20…
- For the first time in over 30 years, FDA has approved a “true generic version” of Premarin. “It took a very long time to approve a generic [for Premarin] because it’s so complicated,” said Janet Woodcock, who served as CDER director for over 20 years. cancerletter.com/clinical/20260123_1/
- The larger legislation that includes the Mikaela Naylon Give Kids a Chance Act, championed for more than five years by @KIDSvCANCER's Nancy Goodman, is now expected to fail as the Senate debates DHS funding after the ICE shooting of Alex Pretti. cancerletter.com/capitol-hill/202601…
- Elizabeth Jaffee and Antoni Ribas named editors-in-chief of the AACR Journal Cancer Immunology Research (@theaacr.bsky.social, @aacrjournals.bsky.social) cancerletter.com/in-brief/20260123_8c/
- Elenagen DNA-based therapy achieves significant reduction in mortality and increase in OS in PROC (@mcgill.ca) cancerletter.com/clinical-roundup/20…
- E. Anders Kolb, MD: "Patients fear a disruption in their access to care and we are already seeing an upheaval in the research infrastructure that fuels life-saving innovations, ultimately putting patients and caregivers at risk." cancerletter.com/guest-editorial/202…
- Tanya Dorff, MD/@cityofhope.bsky.social: "Managing unique toxicities, such as cytokine release syndrome, requires robust education and multidisciplinary coordination." cancerletter.com/sponsored-article/2…
- Workforce shortages will threaten access to cancer care, President’s Cancer Panel says in a report cancerletter.com/cancer-policy/20260…
- The U.S. House passed a minibus package Jan. 22 that was expected to become the grand finale of the FY26 appropriations process. Senate Dems have now blocked the package, which includes DHS funding, following the Jan. 24 ICE shooting of Alex Pretti. cancerletter.com/capitol-hill/202601…
- The fate of the House-passed FY26 funding legislative package—which includes a small pediatric cancer provision, The Mikaela Naylon Give Kids a Chance Act—is now in question as Senate debates funding bill for DHS after ICE shootings. cancerletter.com/capitol-hill/202601…
